ENTRY       D00829                      Drug
NAME        Eflornithine hydrochloride (USAN);
            Vaniqa (TN)
PRODUCT     VANIQA (Allergan)
FORMULA     C6H12F2N2O2. HCl. H2O
EXACT_MASS  236.0739
MOL_WEIGHT  236.6447
REMARK      ATC code: D11AX16 P01CX03
            Chemical structure group: DG00440
            Product (DG00440): D00829<US>
EFFICACY    Antineoplastic, Antiprotozoal, Ornithine decarboxylase inhibitor
TARGET      ODC1 [HSA:4953] [KO:K01581]
  PATHWAY   hsa00330(4953)  Arginine and proline metabolism
            hsa00480(4953)  Glutathione metabolism
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AX Other dermatologicals
                 D11AX16 Eflornithine
                  D00829  Eflornithine hydrochloride (USAN) &lt;US&gt;
             P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
              P01 ANTIPROTOZOALS
               P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
                P01CX Other agents against leishmaniasis and trypanosomiasis
                 P01CX03 Eflornithine
                  D00829  Eflornithine hydrochloride (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Dermatological Agents, Miscellaneous
                Eflornithine
                 D00829  Eflornithine hydrochloride (USAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Lyases (EC4)
               Carboxy-lyases
                ODC1
                 D00829  Eflornithine hydrochloride (USAN) &lt;US&gt;
            Antimicrobials [BR:br08307]
             Antiparasitics
              Agents against Leishmaniasis and Trypanosomiasis
               Others
                D00829  Eflornithine hydrochloride (USAN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00829
DBLINKS     CAS: 96020-91-6
            PubChem: 7847894
            ChEBI: 4762
            LigandBox: D00829
            NIKKAJI: J2.208.704E
ATOM        14
            1   C1d C    18.3240  -17.0568
            2   C1b C    19.5346  -17.7586
            3   C6a C    18.3123  -15.6532
            4   C1c C    17.1193  -17.7586
            5   N1a N    18.3123  -18.4428
            6   C1b C    20.7452  -17.0568
            7   O6a O    19.5229  -14.9339
            8   O6a O    17.0900  -14.9573
            9   X   F    15.9028  -17.0626
            10  X   F    17.1193  -19.1563
            11  C1b C    21.9558  -17.7586
            12  N1a N    23.1722  -17.0568
            13  O0  O    27.7514  -16.7234
            14  X   Cl   27.3700  -18.6200
BOND        11
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     4  10 1
            10    6  11 1
            11   11  12 1
///
